OrthAlign Launches Lantern Handheld Knee Arthroplasty Technology in Japan
Lantern Handheld Technology has application in the planning of total, partial and revision knee replacement cases....
May 14, 2024,
OrthAlign Launches Lantern Handheld Knee Arthroplasty Technology in Japan
IMPLANET Gains 510(k) for Hybrid Jazz Spinal Fixation
Jazz Spinal includes a complete system to treat pediatric deformity and a comprehensive range for the treatment of adult spinal...
May 14, 2024,
Anika Therapeutics Reiterates 2024 Guide, Cuts Costs
The company's orthopedic sales grew in the mid-single-digits during 1Q24 as the company reduced headcount to control costs....
May 14, 2024,
Vericel Keeps Momentum Ahead of MACI Arthro Launch
The company's MACI sales grew nearly 18% in the first quarter of 2024 with the launch of MACI Arthro expected...
May 14, 2024,
Paragon 28 Takes Sequential Step Up in Record Quarter
The company grew more than 17% in the first quarter of 2024 despite a difficult comparison and one less selling...
May 13, 2024,
Treace Medical Reduces 2024 Guide on Competitive Headwinds
The company grew more than 20% in the first quarter of 2024 but lowered its full-year guidance due to increased...
May 13, 2024,
Exactech Launches New ExactechGPS Software
The company unveiled the next evolution of its ligament-driven balancing technology with new ExactechGPS software that accommodates patient-centric planning and...
May 13, 2024,
ATEC Sees Market Disruption As Long Tail Growth Driver
The company grew 27% in the first quarter of 2024 as it further capitalized on disruption in the spine market....
May 10, 2024,
Bioventus Opens 2024 With Strong Growth Across Biologics Businesses
The company drove strong results for its non-surgical hyaluronic acid pain treatments and surgical bone graft substitutes....
May 10, 2024,
Orthofix Medical Delivering on Key Priorities to Start 2024
The company grew in the high single digits for the first quarter of 2024, including above-market growth in the United...
May 09, 2024,
Loading new posts...
No more posts
